is a chronic cutaneous and subcutaneous disease caused by melanised fungi. It is usually associated with traumatic inoculation and occurs in the lower extremities. The treatment of this infectious disease remains challenging because of the diversity of clinical manifestations and aetiological agents. Without proper treatment, the disease can lead to incapacity in the work due to fibrotic sequelae or other complications. In worst cases, it can lead to skin cancer. 1 The aetiological agents of CBM are Fonsecaea, Phialophora, Cladophialophora, Rhinocladiella and Exophiala, among them the genus Fonsecaea is the most common. The species of the genus Fonsecaea comprises four species: F pedrosoi, F monophora, F nubica and F pugnacius. 2 F monophora and F pugnacious show significant neurotropism, which eventually leads to transmission to the brain and other organs. 3,4 In southern China, chromoblastomycosis is mainly caused by Fonsecaea pedrosoi and Fonsecaea monophora. Here, we presented a case of chromoblastomycosis with 20-year duration caused by F monophora. Clinical manifestations were not only included typical plaques and scales, but also appeared recurrent keratinised protrusions, and the infection lasted for a long time and involved an entire forearm. We observed a positive clinical effect of oral antifungal drugs, retinoid combined with carbon dioxide laser and ALA-PDT.